The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders

The frequency of zinc deficiency, copper toxicity and low zinc/copper in children with autism spectrum disorders (ASDs) may indicate decrement in metallothionein system functioning. A retrospective review of plasma zinc, serum copper and zinc/copper was performed on data from 230 children with autis...

Full description

Saved in:
Bibliographic Details
Published inBiomarkers Vol. 14; no. 3; pp. 171 - 180
Main Authors Faber, Scott, Zinn, Gregory M., Kern II, John C., Skip Kingston, H. M.
Format Journal Article
LanguageEnglish
Published London Informa UK Ltd 01.05.2009
Taylor & Francis
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The frequency of zinc deficiency, copper toxicity and low zinc/copper in children with autism spectrum disorders (ASDs) may indicate decrement in metallothionein system functioning. A retrospective review of plasma zinc, serum copper and zinc/copper was performed on data from 230 children with autistic disorder, pervasive developmental disorder-NOS and Asperger's syndrome. The entire cohort's mean zinc level was 77.2 μg dl−1, mean copper level was 131.5 μg dl−1, and mean Zn/Cu was 0.608, which was below the 0.7 cut-off of the lowest 2.5% of healthy children. The plasma zinc/serum copper ratio may be a biomarker of heavy metal, particularly mercury, toxicity in children with ASDs.
ISSN:1354-750X
1366-5804
DOI:10.1080/13547500902783747